CrossrefInfokarte
Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once-Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma: A Phase II Study
Transplantation and Cellular Therapy · 2026-11 · 32 (11) · 1415.e1-1415.e5
DOI: 10.1016/j.jtct.2026.06.034 ↗Abstract
Kein Abstract verfügbar.
EUVIMED